|
| | 10200HB0033ham001 | - 2 - | LRB102 04106 BMS 25297 a |
|
|
| 1 | | (2) limit the amount, extent, or kind of coverage |
| 2 | | available to the individual; or |
| 3 | | (3) charge the individual or a group to which the |
| 4 | | individual belongs a rate that is different from the rate |
| 5 | | charged to other individuals or groups, respectively, for |
| 6 | | the same coverage, unless the charge is based on sound |
| 7 | | underwriting or actuarial principles reasonably related to |
| 8 | | actual or anticipated loss experience for a particular |
| 9 | | risk. |
| 10 | | (215 ILCS 5/155.48 new) |
| 11 | | Sec. 155.48. Prohibited practices relating to prescription |
| 12 | | for or obtainment of opioid antagonist. |
| 13 | | (a) As used in this Section, "opioid antagonist" means any |
| 14 | | drug that binds to opioid receptors and blocks or otherwise |
| 15 | | inhibits the effects of opioids acting on those receptors to |
| 16 | | reverse the effects of an opioid overdose. |
| 17 | | (b) A company authorized to transact life insurance in |
| 18 | | this State may not, based solely on whether an individual has |
| 19 | | been prescribed or has obtained through a standing order an |
| 20 | | opioid antagonist: |
| 21 | | (1) deny coverage to the individual; |
| 22 | | (2) limit the amount, extent, or kind of coverage |
| 23 | | available to the individual; or |
| 24 | | (3) charge the individual or a group to which the |
| 25 | | individual belongs a rate that is different from the rate |